Darin Lippoldt, Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 8,752 shares at $159.65 ($1.4M) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($1.4M) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $159.65 | 4,376 | $699K | 50.0% |
| 2 | $159.65 | 4,376 | $699K | 50.0% |
| Total | $159.65 avg | 8,752 | $1.4M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $510K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $215K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $382K | — | Filing → |